T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis

Stanford University

Status: Completed

Conditions: Leukemia, Lymphocytic, Acute

Treatments: Procedure: bone marrow aspiration; Procedure: peripheral blood sampling

Study type: Observational

Funder types: Other

Identifiers

NCT01078337

SU-11022007-790

PEDSALL0001

Details and patient eligibility

About

To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).

Enrollment: 15 estimated patients

Sex: All

Ages: Under 18 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Children with newly diagnosed T-cell ALL